GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a prominent focus in therapeutic investigation, largely due to its impressive impact on managing diseases such as type 2 diabetes and obesity. Ongoing studies have revealed that beyond glucose regulation, GLP-1 medications offer promise for circulatory function and p